Coty adds Home Skin Lab to its portfolio
PARIS A division of beauty and fashion giant Coty will add another brand to its portfolio, the company has announced.
On Friday, Coty Prestige introduced Home Skin Lab by the Dr Pastorek Institute, a brand inspired by plastic surgeon Dr. Norman Pastorek.
“Given Dr. Pastorek’s experience and the utmost respect he and his wife have earned throughout the medical community, Coty could not have partnered with a more appropriate team to create top-of the line Skin care products,” said Michele Scannavini, President, Coty Prestige.
The product is available in five protocols, each comprising a 28-day treatment: Ageless, which guards against the signs of aging; Wrink’less, which reduces wrinkes; Firmness, which increases skin density; Brightness, to improve dull complexions; and Pureness, which reduces skin oils.
“Home Skin Lab by Dr Pastorek Institute is an opportunity for Coty Prestige to enter the cosmeceutical segment which is growing at a tremendous pace in the United States and is starting to make significant inroads in the rest of the world,” Scannavini said.
Home Skin Lab will become available in the U.S. and Europe in September.
Allergan announces intent to file eyelash stimulant with FDA
IRVINE, Calif. Allergan announced today that it intends to file an application with the Food and Drug Administration for bimatoprost, a synthetic prostaglandin analog, as a treatment to stimulate eyelash growth, by end of the third quarter of 2008 after receiving promising results from a clinical trial.
“Our exploration of bimatoprost as an eyelash growth enhancer reflects our continuing commitment to offer innovative medical aesthetic treatments that are science-based, with the clinically proven safety and efficacy that consumers have come to trust Allergan to provide,” said Scott Whitcup, Allergan’s executive vice president, research and development. “We are pleased with the results of our clinical program and believe this innovative product, if approved, could meet a significant and currently unmet demand in the medical aesthetic marketplace.”
According to Allergan, the global mascara market is presently estimated to be $3.7 billion annually. Allergan currently anticipates the product to be approved by the FDA in 2009 and to have annual sales that exceed $500 million.
Sephora extends Acxiom contract for two years
LITTLE ROCK, Ark. Beauty retailer Sephora has extended its contract with Acxiom for integrated digital marketing solutions for an additional two years.
Acxiom has been working with Sephora since September 2005, providing the technology platform and digital marketing services that power the retailer’s integrated digital marketing communications to email subscribers and loyalty program members, Beauty Insiders.
For example, using Acxiom’s IMPACT technology platform, Sephora is able to incorporate more complex rules for segmenting customers based on their beauty profile, according to Acxiom. The retailer can now tailor product recommendations and special offers based on traits such as eye and hair color or skin type.
In addition, Sephora is using Acxiom’s integrated transactional messaging capabilities to create HTML email communications for shipping confirmations. Before implementing Acxiom’s platform, these transactional communications were sent as plain text messages, leaving little room for branding, up-sell or cross-sell opportunities.